News
CVS Health Corp. raised its profit guidance for the year after posting strong results in its health insurance and pharmacy ...
Investors sometimes buy shares in companies with bleak financial prospects, known as "meme stocks." These stocks often gain ...
1d
Zacks Investment Research on MSNGameStop (GME) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest trading session, GameStop (GME) closed at $22.55, marking a -1.87% move from the previous day. This move lagged the S&P 500's daily loss of 0.3%. On the other hand, the Dow registered a ...
Real estate investment trust BXP , formerly known as Boston Properties, on Tuesday raised its full-year outlook after reporting better-than-expected second-quarter results, driven by strong leasing ...
1d
Zacks Investment Research on MSNGameStop vs. Best Buy: Which Retail Stock Has Better Upside?
GameStop Corp. GME and Best Buy Co., Inc. BBY stand at very different crossroads in the retail landscape. GameStop, once heavily dependent on physical video game sales, is in the midst of a deep ...
In the closing of the recent trading day, GameStop (GME) stood at $23.96, denoting a -1.24% move from the preceding trading day.
So hardly any stocks are moving lower, and those that are aren't seeing much volume, which can turn into a "sign of excessive bullishness," Thrasher said. At extremes, it turns into a sort-of ...
Taiwan Semiconductor Manufacturing, known as TSMC, reported a 61% rise in quarterly profit as it benefits from demand for artificial-intelligence processors.
Key Takeaways GameStop posted a surprise profit but continues to lose revenue in core retail.The company is shifting into ...
Johnson & Johnson shares surged Wednesday after the company reported second-quarter results that topped estimates and the company lifted its full-year outlook.
In a strategic repositioning, the GameStop CEO hints at a willingness to accept cryptocurrency in exchange of trading ...
Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and profit forecast on Wednesday after a strong quarter for flagship cancer drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results